KDR and neoplasm: Normalization of tumor vasculature with an appropriate dose of anti-angiogenic treatment, primarily through disruption of the VEGF/VEGFR axis, is able to reduce tissue hypoxia and reprogram the tumor microenvironment from immunosuppressive to immunoactive (210, 211).